ArticleJournal of clinical and translational science2019

Preclinical Studies of RUC-4, a Novel Platelet αIIbβ3 Antagonist, in Non-Human Primates and With Human Platelets.

Spandana Vootukuri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.